BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 24391131)

  • 1. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
    Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
    FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.
    Srivastav S; Saha A; Barua J; Ukil A; Das PK
    Eur J Immunol; 2015 Oct; 45(10):2787-97. PubMed ID: 26140693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.
    Srivastav S; Kar S; Chande AG; Mukhopadhyaya R; Das PK
    J Immunol; 2012 Jul; 189(2):924-34. PubMed ID: 22685311
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Parmar N; Chandrakar P; Vishwakarma P; Singh K; Mitra K; Kar S
    J Immunol; 2018 Aug; 201(3):957-970. PubMed ID: 29907707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3.
    Zhong B; Liu X; Wang X; Liu X; Li H; Darnay BG; Lin X; Sun SC; Dong C
    Sci Signal; 2013 May; 6(275):ra35. PubMed ID: 23674823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20.
    Das S; Pandey K; Kumar A; Sardar AH; Purkait B; Kumar M; Kumar S; Ravidas VN; Roy S; Singh D; Das P
    Immunol Cell Biol; 2012 Jul; 90(6):640-54. PubMed ID: 21968712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.
    Lin YC; Huang DY; Chu CL; Lin YL; Lin WW
    Sci Signal; 2013 Aug; 6(289):ra71. PubMed ID: 23962979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania donovani activates SREBP2 to modulate macrophage membrane cholesterol and mitochondrial oxidants for establishment of infection.
    Mukherjee M; Basu Ball W; Das PK
    Int J Biochem Cell Biol; 2014 Oct; 55():196-208. PubMed ID: 25218172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection.
    Paul J; Naskar K; Chowdhury S; Alam MN; Chakraborti T; De T
    Indian J Biochem Biophys; 2014 Dec; 51(6):531-41. PubMed ID: 25823227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages.
    Flandin JF; Chano F; Descoteaux A
    Eur J Immunol; 2006 Feb; 36(2):411-20. PubMed ID: 16369915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes.
    Campo GM; Avenoso A; Campo S; D'Ascola A; Nastasi G; Calatroni A
    Biochimie; 2010 Feb; 92(2):204-15. PubMed ID: 19879319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
    J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 promotes control of Leishmania infantum infection through inducement of leishmanicidal activity in host macrophages: role of mitogen activated kinases.
    Agallou M; Dotsika E; Frydas S; Karagouni E
    J Biol Regul Homeost Agents; 2014; 28(1):41-52. PubMed ID: 24750790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J; Karmakar S; De T
    Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay Between Sialic Acids, Siglec-E, and Neu1 Regulates MyD88- and TRIF-Dependent Pathways for TLR4-Activation During
    Karmakar J; Mandal C
    Front Immunol; 2021; 12():626110. PubMed ID: 33763070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering Leishmania-macrophage interplay using imaging flow cytometry.
    Terrazas C; Oghumu S; Varikuti S; Martinez-Saucedo D; Beverley SM; Satoskar AR
    J Immunol Methods; 2015 Aug; 423():93-8. PubMed ID: 25967951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.